Novartis planning 14 OTC brand sale to "streamline" portfolio: Acutrim, Fiberall on block.
This article was originally published in The Tan Sheet
Executive Summary
NOVARTIS LOOKING TO SELL ACUTRIM, FIBERALL, 12 OTHER OTC BRANDS TO "STREAMLINE" product sales, the company said Jan. 13. Newly-formed Novartis is putting the 14 products on the block "as part of a strategic plan to streamline its current OTC product portfolio" so it can "focus on key brands following its merger." The marriage of Ciba and Sandoz to form Summit, N.J.-based Novartis was completed Dec. 20 ("The Tan Sheet" Dec. 23, 1996, p. 26).